Tag Archives: BioTherapeutics

Nasdaq-listed Sonnet BioTherapeutics agrees to $888 million merger to become Hyperliquid Strategies, launch HYPE treasury  The Block Massive $888M Deal: Biotech Firm Makes Historic Pivot to Become Largest US Public HYPE Token Holder  Stock Titan Sonnet BioTherapeutics jumps over 320%, combines business for HYPE crypto reserve (SONN:NASDAQ)  Seeking Alpha Sonnet BioTherapeutics, Inc. Announces $888 Million  GlobeNewswire Why Is Sonnet BioTherapeutics Stock (SONN) Up 180% …

PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced that it has entered into a definitive agreement (the “Business Combination Agreement”, or the “BCA”) for a business combination (the “Business Combination”) with Rorschach I LLC (“Rorschach”), a newly-formed entity formed by an entity affiliated with Atlas Merchant Capital LLC (“Atlas”), …